PharmGen Science, Inc.
004720.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$62.67B
Close$
Share Statistics
| Market cap | $62.67 Billion |
|---|---|
| Enterprise Value | $44.63 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5312.85 |
| Beta | 0.24 |
| Outstanding Shares | 22,122,000 |
Return
| Return on Equity | -95.95% |
|---|---|
| Return on Assets | -72.95% |
| Return on Invested Capital | 2.49% |
Valuation & Multiples
| P/E Ratio | -0.47 |
|---|---|
| PEG | 0.1 |
| Price to Sales | 0.35 |
| Price to Book Ratio | 0.44 |
| Enterprise Value to Revenue | 0.25 |
| Enterprise Value to EBIT | 11.45 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PharmGen Science, Inc.
229 employees
CEO: Hee-Deok Park PharmGen Science, Inc., originally founded in 1961 as Wooridul Pharmaceutical Limited, is a South Korean company primarily involved in the research, development, manufacturing, and distribution of pharmaceutical products. Based in Hwaseo...